v3.25.2
Consolidated Condensed Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 165,208 $ 295,305
Receivables, net of allowance for doubtful accounts 117,667 84,325
Inventories:    
Finished goods 24,499 24,022
Work in process 33,529 36,705
Raw materials 89,233 82,681
Total inventories 147,261 143,408
Prepaid expenses and other current assets 18,139 17,078
Total current assets 448,275 540,116
Property, plant and equipment, at cost 244,748 233,203
Less accumulated depreciation (166,811) (158,943)
Net property, plant and equipment 77,937 74,260
Intangible assets, at cost less accumulated amortization 126,109 45,066
Other assets 15,708 12,676
Deferred income taxes 32,692 32,525
Goodwill 235,699 111,770
Total assets 936,420 816,413
Current liabilities:    
Payables 74,125 55,659
Accrued compensation and employee benefits 23,825 34,912
Warranty and after-sale costs, current 9,828 7,283
Other current liabilities 30,932 20,351
Total current liabilities 138,710 118,205
Long-term deferred revenue 68,545 64,153
Deferred income taxes 24,109 3,652
Accrued non-pension postretirement benefits 3,340 3,033
Other accrued employee benefits 7,563 6,927
Warranty and after-sale costs, long-term 9,721 9,410
Other long-term liabilities 6,840 4,801
Commitments and contingencies (Note 5)
Shareholders’ equity:    
Common stock, $1 par, authorized 80,000,000, issued 37,221,098 shares in 2025 and 2024 37,221 37,221
Capital in excess of par value 70,505 65,819
Reinvested earnings 600,763 547,796
Accumulated other comprehensive income (loss) 5,529 (7,906)
Less: Treasury stock, at cost, 7,752,290 shares in 2025 and 7,810,158 in 2024 (36,426) (36,698)
Total shareholders’ equity 677,592 606,232
Total liabilities and shareholders’ equity $ 936,420 $ 816,413